scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...629060M |
P356 | DOI | 10.1371/JOURNAL.PONE.0029060 |
P932 | PMC publication ID | 3240642 |
P698 | PubMed publication ID | 22194989 |
P5875 | ResearchGate publication ID | 51921104 |
P50 | author | Cecilia Magnusson | Q42306048 |
P2093 | author name string | Jian Liu | |
Anita Sjölander | |||
Minghui Liu | |||
Roy Ehrnström | |||
Yvonne Ceder | |||
Astrid M Bengtsson | |||
P2860 | cites work | Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression. | Q52013322 |
Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. | Q52552851 | ||
The establishment of strains of human cells in tissue culture. | Q52831945 | ||
Heterogeneity of mucin gene expression in normal and neoplastic tissues | Q53482902 | ||
Characterization of the human cysteinyl leukotriene CysLT1 receptor | Q22010199 | ||
Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages | Q24297421 | ||
Innate immune recognition of viral infection | Q24498364 | ||
Inflammation and cancer | Q24649640 | ||
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor | Q24672638 | ||
Inflammation and cancer: back to Virchow? | Q28036756 | ||
Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas | Q28201753 | ||
Interferons at age 50: past, current and future impact on biomedicine | Q28259312 | ||
Interferons, interferon-like cytokines, and their receptors | Q28293630 | ||
Colorectal cancer in mice genetically deficient in the mucin Muc2 | Q28588769 | ||
Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection | Q29618129 | ||
Characterization of the human cysteinyl leukotriene 2 receptor | Q30305734 | ||
Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells | Q30438955 | ||
Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2 | Q33200951 | ||
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status | Q33620091 | ||
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis | Q33683729 | ||
Epidermal growth factor receptor: mechanisms of activation and signalling. | Q34185055 | ||
Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells | Q34207335 | ||
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation | Q34254403 | ||
Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure | Q34368064 | ||
Interferon-alpha in tumor immunity and immunotherapy | Q34568695 | ||
IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes. | Q34615084 | ||
Ulcerative colitis and colorectal cancer. A population-based study | Q34634203 | ||
Biologic therapy of inflammatory bowel disease. | Q34642879 | ||
CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells | Q34662206 | ||
Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines | Q35764436 | ||
Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses | Q35841909 | ||
Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. | Q36376782 | ||
Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer | Q36404654 | ||
Interferon signalling network in innate defence | Q36471845 | ||
Leukotriene receptors in atherosclerosis | Q36652544 | ||
Role of eicosanoids as mediators of inflammation in inflammatory bowel disease | Q37590359 | ||
Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients | Q39658216 | ||
Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells. | Q39910840 | ||
Signaling by the cysteinyl-leukotriene receptor 2. Involvement in chemokine gene transcription | Q40042544 | ||
A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. | Q40459685 | ||
Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression | Q40513415 | ||
Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and upregulation of alpha2beta1-integrin | Q40633490 | ||
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. | Q40852996 | ||
New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine | Q41354692 | ||
Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer | Q43197500 | ||
Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation | Q43582803 | ||
Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407. | Q44329577 | ||
Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. | Q44484476 | ||
Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation | Q44539655 | ||
Effect of polyunsaturated fatty acid-enriched phosphatidylcholine and phosphatidylserine on butyrate-induced growth inhibition, differentiation and apoptosis in Caco-2 cells | Q45222219 | ||
Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients | Q46817033 | ||
Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes | Q46946616 | ||
An increased expression of cysteinyl leukotriene 2 receptor in colorectal adenocarcinomas correlates with high differentiation | Q46972184 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e29060 | |
P577 | publication date | 2011-12-15 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Regulation of cysteinyl leukotriene receptor 2 expression--a potential anti-tumor mechanism | |
P478 | volume | 6 |
Q39042181 | 5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation. |
Q38129012 | Are GPCRs still a source of new targets? |
Q35048508 | Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia |
Q28308101 | Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer |
Q28074285 | Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer |
Q34799962 | The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells |
Search more.